Daly James M (CIK 1560782) reported 12 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy MDGL (454 shares), Buy ACAD (8,107 shares), Buy CYTK (191 shares), Buy CYTK (197 shares), Sell ACAD (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Buy | 454 | $0 |
| 2026-06-01 | ACADIA PHARMACEUTICALS INC (ACAD) | Director | Buy | 8,107 | $0 |
| 2026-04-15 | CYTOKINETICS INC (CYTK) | Director | Buy | 191 | $12,486 |
| 2026-01-20 | CYTOKINETICS INC (CYTK) | Director | Buy | 197 | $12,498 |
| 2025-11-12 | ACADIA PHARMACEUTICALS INC (ACAD) | Director | Sell | 30,000 | $671,100 |
| 2025-06-24 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Buy | 715 | $0 |
| 2025-06-02 | ACADIA PHARMACEUTICALS INC (ACAD) | Director | Buy | 9,387 | $0 |
| 2025-02-28 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Buy | 9,470 | $616,118 |
| 2025-02-28 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Buy | 6,000 | $666,360 |
| 2025-02-28 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Sell | 398 | $138,066 |
| 2025-02-28 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Sell | 14,302 | $5.0M |
| 2025-02-28 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | Sell | 770 | $268,684 |
Source: SEC Form 4 filings · as of 2026-06-18